This item requires a subscription to Annals of Internal Medicine.
Please note: Some PDFs are free 6 months after publication.
Full Text
Brief Communications:Anti-CD20 Chimeric Monoclonal Antibody Treatment of Refractory Immune-Mediated Thrombocytopenia in a Patient with Chronic
Graft-versus-Host Disease